Geneva: The World Health Organization approved the Sinovac Covid-19 vaccine for emergency use — the second Chinese jab to receive the WHO’s green light.
The WHO’s Strategic Advisory Group of Experts on Immunization reviewed the jab and published their advice on its usage.
“WHO recommends the vaccine for use in adults 18 years and older, in a two-dose schedule with a spacing of two to four weeks,” the agency said.
The move gives countries, funders, procuring agencies and communities “assurance that it meets international standards for safety, efficacy, and manufacturing”.
Last month Sinopharm became the first Chinese vaccine to be approved by the WHO.
WHO’s listing paves the way for countries worldwide to quickly approve and import a vaccine for distribution, especially those states without an international-standard regulator of their own.
The Sinovac jab is already in use in 22 territories around the world, according to an AFP count.
